Gąsior-Perczak, D.; Kowalik, A.; Walczyk, A.; Siołek, M.; Gruszczyński, K.; Pałyga, I.; Mikina, E.; Trybek, T.; Kopczyński, J.; Mężyk, R.;
et al. Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course. Cancers 2019, 11, 1744.
https://doi.org/10.3390/cancers11111744
AMA Style
Gąsior-Perczak D, Kowalik A, Walczyk A, Siołek M, Gruszczyński K, Pałyga I, Mikina E, Trybek T, Kopczyński J, Mężyk R,
et al. Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course. Cancers. 2019; 11(11):1744.
https://doi.org/10.3390/cancers11111744
Chicago/Turabian Style
Gąsior-Perczak, Danuta, Artur Kowalik, Agnieszka Walczyk, Monika Siołek, Krzysztof Gruszczyński, Iwona Pałyga, Estera Mikina, Tomasz Trybek, Janusz Kopczyński, Ryszard Mężyk,
and et al. 2019. "Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course" Cancers 11, no. 11: 1744.
https://doi.org/10.3390/cancers11111744
APA Style
Gąsior-Perczak, D., Kowalik, A., Walczyk, A., Siołek, M., Gruszczyński, K., Pałyga, I., Mikina, E., Trybek, T., Kopczyński, J., Mężyk, R., Góźdź, S., & Kowalska, A.
(2019). Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course. Cancers, 11(11), 1744.
https://doi.org/10.3390/cancers11111744
